SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/19/11 Accentia Biopharmaceuticals Inc 10-K 9/30/11 53:7M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.37M 2: EX-10.57 Royalty Termination Agreement HTML 26K 3: EX-10.58 Class 4 Plan Promissory Note HTML 33K 4: EX-10.59 Stock Pledge Agreement HTML 68K 5: EX-10.60 Asset Purchase Agreement HTML 314K 6: EX-10.61 Agreement HTML 30K 7: EX-10.62 Loan Security Termination Agreement HTML 37K 8: EX-10.63 Loan Prepayment, Modification and Security HTML 40K Termination Agreement 9: EX-10.64 Amended and Restated Secured Term Note HTML 58K 10: EX-10.65 Amended and Restated Secured Term Note HTML 58K 11: EX-10.66 Amended and Restated Secured Term Note HTML 58K 12: EX-10.67 Amended and Restated Secured Term Note HTML 58K 13: EX-21 Subsidiaries of Accentia HTML 14K 14: EX-31.1 Certification -- §302 - SOA'02 HTML 22K 15: EX-31.2 Certification -- §302 - SOA'02 HTML 22K 16: EX-32.1 Certification -- §906 - SOA'02 HTML 16K 17: EX-32.2 Certification -- §906 - SOA'02 HTML 16K 36: R1 Document And Entity Information HTML 45K 29: R2 Consolidated Balance Sheets HTML 182K 34: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K 38: R4 Consolidated Statements Of Operations HTML 129K 49: R5 Consolidated Statements Of Stockholders' Deficit HTML 123K 30: R6 Consolidated Statements Of Cash Flows HTML 216K 33: R7 Company Overview And Summary Of Significant HTML 84K Accounting Policies 27: R8 Liquidity And Management's Plans HTML 103K 25: R9 Discontinued Operations HTML 52K 50: R10 Inventories HTML 25K 40: R11 Unbilled Receivables And Unearned Revenues HTML 32K 39: R12 Intangible Assets HTML 39K 44: R13 Furniture, Equipment And Leasehold Improvements HTML 31K 45: R14 Reserve For Unresolved Claims HTML 18K 43: R15 Note Payable HTML 18K 46: R16 Convertible Long-Term Debt HTML 98K 35: R17 Other Long-Term Debt HTML 73K 37: R18 Derivative Liabilities HTML 65K 42: R19 Related Party Transactions HTML 51K 53: R20 Liabilities Subject To Compromise HTML 35K 47: R21 Income Taxes HTML 55K 31: R22 Stockholders' Equity HTML 98K 41: R23 Employee Benefit Plan HTML 21K 32: R24 Commitments And Contingencies HTML 59K 24: R25 Variable Interest Entities HTML 27K 48: R26 Pro Forma Results HTML 21K 51: R27 Subsequent Events HTML 32K 52: XML IDEA XML File -- Filing Summary XML 56K 26: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 698K 18: EX-101.INS XBRL Instance -- abpi-20110930 XML 868K 20: EX-101.CAL XBRL Calculations -- abpi-20110930_cal XML 158K 21: EX-101.DEF XBRL Definitions -- abpi-20110930_def XML 62K 22: EX-101.LAB XBRL Labels -- abpi-20110930_lab XML 582K 23: EX-101.PRE XBRL Presentations -- abpi-20110930_pre XML 353K 19: EX-101.SCH XBRL Schema -- abpi-20110930 XSD 77K 28: ZIP XBRL Zipped Folder -- 0001193125-11-345824-xbrl Zip 107K
Download this zipped .zip folder. | |
Files: | abpi-20110930.xml abpi-20110930_cal.xml abpi-20110930_def.xml abpi-20110930_lab.xml abpi-20110930_pre.xml abpi-20110930.xsd |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/14/12 SEC UPLOAD¶ 10/20/17 1:47K Accentia Biopharmaceuticals Inc. 3/07/12 SEC UPLOAD¶ 10/20/17 1:58K Accentia Biopharmaceuticals Inc. |